MA.32
NCT01286233
MA32
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
Status:
Closed to Accrual
III
Phase
n/a
Line of Therapy
Early Cancer
Disease Stage
Biomarker(s)
N/A
Investigational
Product
Metformin
Antihyperglycemic agent
Treatment Arms
o Group 1: Metformin
o Group 2: Placebo